Huda Taha

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor (INSTI), which has now been licensed to be used in different countries including the UK. Earlier studies have demonstrated that DTG when used with nucleoside backbone in treatment-naïve and - experienced patients has been well tolerated and demonstrated virological suppression(More)
  • 1